MEDANOVA

Kenneth J. Sultzbaugh, Ph.D has over 20 years of experience in the pharmaceutical industry with extensive experience in the formulation and process development of oral solid dosage forms. Ken has led efforts to develop a variety of solid dosage forms including immediate release tablets and capsules, modified release tablets and capsules, multiparticulate-containing capsules, softgels and orally-disintegrating tablets. Ken has 2 U.S. patents with 1 pending, 2 publications and made 5 presentations and regional, national and international meetings. Prior to founding Medanova, Ken held positions of increasing responsibility with Whitehall-Robins, Johnson & Johnson and Catalent Pharma Solutions. Ken has a B.S. in Pharmacy and Ph.D. in Pharmaceutical Sciences from Temple University and a M.S. in Statistics and Biostatistics from Rutgers University. Ken is a member of the American Association of Pharmaceutical Scientists.